Incisive Genetics - Crunchbase Company Profile & Funding

Q: Who invested in Incisive Genetics?

Incisive Genetics has 4 investors including Noel Hall And Sandra MacPherson.

Q: When was the last funding round for Incisive Genetics?

Incisive Genetics closed its last funding round on obfuscated from a Seed round.

Q: How much funding has Incisive Genetics raised to date?

Incisive Genetics has raised obfuscated.

Overview

Incisive Genetics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Incisive Genetics

CB Rank

97665

Incisive Genetics is developing a delivery platform for genetic therapies.

Founded

obfuscation

Private

Seed

Vancouver, British Columbia, Canada

11-50

www.incisivegenetics.com/

Biotechnology

Genetics

Health Care

Medical Device

Funding Rounds

Seed

OBF

obfuscation

Angel

OBF

obfuscation

Pre-Seed

OBF

obfuscation

Key People

Pamela Wagner: Co-founder, Director – Technology Development
Blair Leavitt: Co-founder, CEO, Chairman of the Board

Details

Legal Name

Incisive Genetics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Austin Hill, Blair Leavitt, Pamela Wagner

About the Company

IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular genetic

diseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.

Contact Email

info@incisivegenetics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Incisive Delivery System™

A lipid nanoparticle-based non-viral platform delivering pre-formed CRISPR ribonucleoprotein complexes into target cells for gene editing.

Omnia™ Platform

A proprietary non-viral delivery platform for CRISPR-based gene therapies combining active CRISPR proteins, guide RNA, and DNA templates when needed.

Research & Development

Incisive Genetics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed
obfuscated obfuscation	Seed Round - Incisive Genetics	3	obfuscated obfuscation	Haig Farris, Sandra MacPherson	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Noel Hall	—	Seed Round - Incisive Genetics	—
Noel Hall	—	Seed Round - Incisive Genetics	—
Noel Hall	—	Seed Round - Incisive Genetics	—
Noel Hall	—	Seed Round - Incisive Genetics	—
Noel Hall	—	Seed Round - Incisive Genetics	—